Key facts
- This page summarizes Mark D. Kent's Form 4 filing for Cano Health, Inc..
- 7 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 Jul 2024, 16:24.
Mark D. Kent - 28 Jun 2024 Form 4 Insider Report for Cano Health, Inc.
- Reporting relationship
- Interim CEO, Director
- Issuer ticker
- N/A
- Reported as of
- 28 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Jul 2024, 16:24:26 UTC
- Prior SEC filing
- 14 Jul 2023
- Next SEC filing
- 20 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ David J. Armstrong, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mark D. Kent filed Form 4 for Cano Health, Inc. on 02 Jul 2024.
Change
- Previous filing in this sequence was filed on 14 Jul 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CANO
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -15,296
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 28 Jun 2024
- Ownership
- Direct
- Footnotes
- F1, F2
CANO
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -45,995
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 28 Jun 2024
- Ownership
- See Footnote
- Footnotes
- F1, F2, F3
CANO
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -23,609
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 28 Jun 2024
- Ownership
- See Footnote
- Footnotes
- F1, F2, F4
CANO
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -23,609
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 28 Jun 2024
- Ownership
- See Footnote
- Footnotes
- F1, F2, F5
CANO
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -1,749
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 28 Jun 2024
- Ownership
- See Footnote
- Footnotes
- F1, F2, F6
CANO
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -1,749
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 28 Jun 2024
- Ownership
- See Footnote
- Footnotes
- F1, F2, F7
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CANO
transaction
Derivative
New Warrants
Award
- Transaction value
- Shares
- +94,416
- Change %
- Price
- Shares after
- 94,416
- Date
- 28 Jun 2024
- Ownership
- See Footnote
- Underlying class
- New Common Stock
- Underlying amount
- 94,416
- Exercise price
- $25.30
- Footnotes
- F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 8 footnotes
Footnote F1
Beginning on February 4, 2024, the Issuer and certain of its direct and indirect subsidiaries (together with the Issuer, the "Debtors") filed voluntary petitions in the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court"), seeking relief under Chapter 11 of Title 11 of the United States Code. On June 28, 2024, the Bankruptcy Court entered an order confirming the Debtors' Fourth Amended Joint Chapter 11 Plan of Reorganization of Cano Health, Inc. and its Affiliated Debtors (the "Plan"), and on June 28, 2024 (the "Effective Date"), the Plan became effective pursuant to its terms and the Debtors emerged from bankruptcy. On the Effective Date, all outstanding shares of Class A Common Stock of the Issuer (the "Old Common Stock") and warrants, each exercisable for shares of Old Common Stock, were cancelled pursuant to the Plan.
Footnote F2
Reflects the Issuer's 1-for-100 reverse stock split effective as of November 2, 2023.
Footnote F3
These securities are owned directly by Total Health Medical Centers, LLC, which is wholly owned by the reporting person.
Footnote F4
These securities are owned directly by Care Management Resources, LLC, which is wholly owned by the reporting person.
Footnote F5
These securities are owned directly by Procare Medical Management, LLC, which is wholly owned by the reporting person.
Footnote F6
These securities are owned directly by Your Partners in Health, LLC, which is wholly owned by the reporting person.
Footnote F7
These securities are owned directly by Your Partners in Health I, LLC, which is wholly owned by the reporting person.
Footnote F8
Pursuant to the Plan, on the Effective Date, the reporting person received warrants, each exercisable for one share of new common stock of the Issuer (the "New Warrants"). The New Warrants were received for no consideration and are owned directly by Nest Egg Trust LTD, which is wholly owned by the reporting person.